This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Counseling of Pregnant Women During Corona

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04317365
Recruitment Status : Completed
First Posted : March 23, 2020
Last Update Posted : June 4, 2020
Sponsor:
Information provided by (Responsible Party):
Aljazeera Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Corona virus is known as covid 19 And is transmitted through droplet infection

Condition or disease Intervention/treatment Phase
Respiratory Tract Infections Other: Women receiving extra remembering by healthcare Not Applicable

Detailed Description:
Symptoms of Corona include cough Fever and dyspnea
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Effect of Counseling Between Pregnant Women During Corona Infection
Actual Study Start Date : March 24, 2020
Actual Primary Completion Date : April 26, 2020
Actual Study Completion Date : May 25, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pregnancy

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: patients receiving remembering Other: Women receiving extra remembering by healthcare
Women receiving extra remembering by healthcare in covid infection
No Intervention: patients not receiving extra remembering


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. The number of pregnant women who know the exact symptoms of the disease [ Time Frame: Within one month ]
    The number of pregnant women who have awareness about the disease


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 43 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Pregnant women
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • pregnant women

Exclusion Criteria:

  • non pregnant women
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04317365


Locations
Layout table for location information
Egypt
Algazeerah and Kasralainy hospital
Giza, Egypt
Sponsors and Collaborators
Aljazeera Hospital
Investigators
Layout table for investigator information
Study Chair: Mahmoud Alalfy Algezeera hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Aljazeera Hospital
ClinicalTrials.gov Identifier: NCT04317365    
Other Study ID Numbers: Respiratory infection
First Posted: March 23, 2020    Key Record Dates
Last Update Posted: June 4, 2020
Last Verified: June 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Infections
Respiratory Tract Infections
Respiratory Tract Diseases